Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion type Assertion NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_head.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion description "[De novo or augmented inhaled glucocorticoid therapy was associated with significant reductions in the percentages of CD4 T cells expressing IL-5 and IL-4 mRNA, as well as improvements in lung function, symptom scores, and bronchial hyperresponsiveness to metacholine (PD20) in both the atopic and nonatopic asthmatics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_provenance.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion evidence source_evidence_literature NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_provenance.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion SIO_000772 11826234 NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_provenance.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion wasDerivedFrom befree-20150227 NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_provenance.
- NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_assertion wasGeneratedBy ECO_0000203 NP496291.RA0rVWhoBrg_NtWhLsMzKynDmm5TRAfByh8MpA4qu76ys130_provenance.